Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 13/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.48 |
| ▸ | THRB | P10828 | 3/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | RGS12 | O14924 | 1/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.48 |
| ▸ | APEX1 | P27695 | 1/20 | 0.48 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.48 |
| ▸ | RECQL | P46063 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29914719 | 1.00 | KCNH2 (0.50) | KCNH2ALDH1A1HSD17B10THRBMAPK1 | |
| Hydrochloric Acid SCHEMBL104308 | 0.98 | KCNH2 (0.51) | KCNH2ALDH1A1HSD17B10THRBMAPK1 | |
| SCHEMBL3856198 | 0.98 | KCNH2 (0.49) | KCNH2ALDH1A1HSD17B10THRBMAPK1 | |
| SCHEMBL11759545 | 0.83 | KCNH2 (0.66) | KCNH2ALDH1A1HSD17B10THRBMAPK1 | |
| SCHEMBL11759552 | 0.83 | KCNH2 (0.66) | KCNH2ALDH1A1HSD17B10THRBMAPK1 | |
| SCHEMBL374911 | 0.79 | MAPT (0.53) | ALDH1A1THRBMAPK1KDM4EHPGD | |
| SCHEMBL29740108 | 0.79 | MAPT (0.53) | ALDH1A1THRBMAPK1KDM4EHPGD | |
| Hydrochloric Acid SCHEMBL103959 | 0.78 | MAPT (0.51) | ALDH1A1THRBMAPK1KDM4EHPGD | |
| SCHEMBL145777 | 0.78 | ALDH1A1 (0.48) | ALDH1A1HSD17B10THRBMAPK1HIF1A | |
| SCHEMBL144585 | 0.76 | ALDH1A1 (0.47) | KCNH2ALDH1A1HSD17B10THRBMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0403797-A2 | The use of a light stabilizer comprising an aryl nitrogen compound for stabilizing an organic dye | TAIYO YUDEN CO., LTD. (JP) | 1990-12-27 | — | — | EP | claimed |
| JP-1052783-A | — | — | None | — | — | JP | disclosed |
| US-12605468-B2 | Oxazine-based fluorophore compounds for nerve-specific imaging | OREGON HEALTH & SCIENCE UNIVERSITY (US) | 2026-04-21 | — | — | US | disclosed |
| US-12011433-B2 | Mofezolac derivatives as multi-functions selective COX-1 inhibitors | ITEL TELECOMUNICAZIONI S.R.L. (IT) | 2024-06-18 | — | — | US | disclosed |
| EP-3782990-B1 | MOFEZOLAC DERIVATIVE AS IMAGING AGENT IN A DIAGNOSTIC METHOD OF CANCER | UNIV DEGLI STUDI DI BARI ALDO MORO (IT) | 2023-06-07 | — | — | EP | disclosed |
| US-20230148317-A1 | OXAZINE-BASED FLUOROPHORE COMPOUNDS FOR NERVE-SPECIFIC IMAGING | OREGON HEALTH & SCIENCE UNIVERSITY (US) | 2023-05-11 | — | — | US | disclosed |
| US-20230148317-A1 | OXAZINE-BASED FLUOROPHORE COMPOUNDS FOR NERVE-SPECIFIC IMAGING | OREGON HEALTH & SCIENCE UNIVERSITY (US) | 2023-05-11 | — | — | US | disclosed |
| EP-4093443-A1 | OXAZINE-BASED FLUOROPHORE COMPOUNDS FOR NERVE-SPECIFIC IMAGING | Oregon Health & Science University (US) | 2022-11-30 | — | — | EP | disclosed |
| US-11492359-B2 | Near-infrared nerve-sparing fluorophores | OREGON HEALTH & SCIENCE UNIVERSITY (US) | 2022-11-08 | — | — | US | disclosed |
| CN-115279423-A | Oxazine-based fluorophore compounds for neurospecific imaging | 俄勒冈健康与科学大学 | 2022-11-01 | — | — | CN | disclosed |
| US-5847071-A | Photosensitive resin composition | HITACHI, CHEMICAL CO., LTD. (JP) | 1998-12-08 | — | — | US | disclosed |
| US-5844066-A | Process for the preparation of lactic acid-based polyester | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1998-12-01 | — | — | US | disclosed |
| WO-1998003497-A1 | COVALENTLY IMMOBILISED FLUOROIONOPHORES FOR OPTICAL ION SENSORS | NOVARTIS AG (CH) | 1998-01-29 | — | — | WO | disclosed |
| US-5686540-A | Process for the preparation of lactic acid-based polyester | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1997-11-11 | — | — | US | disclosed |
| US-5668248-A | POLYAMIC ACID ESTERS | HITACHI CHEMICAL CO., LTD. (JP) | 1997-09-16 | — | — | US | disclosed |
| EP-0765913-A1 | Process for the preparation of lactic acid-based polyester compositions | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1997-04-02 | — | — | EP | disclosed |
| US-5472823-A | Polyamic acids | HITACHI CHEMICAL CO., LTD. (JP) | 1995-12-05 | — | — | US | disclosed |
| US-5318882-A | Nitrosodiphenylamine compounds render dyes lightfast | TAIYO YUDEN CO., LTD. (JP) | 1994-06-07 | — | — | US | disclosed |
| EP-0403797-A2 | The use of a light stabilizer comprising an aryl nitrogen compound for stabilizing an organic dye | TAIYO YUDEN CO., LTD. (JP) | 1990-12-27 | — | — | EP | disclosed |
| JP-S6452783-A | NOVEL SPIROBENZOXAZINE COMPOUND | TORAY INDUSTRIES | 1989-02-28 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11492359-B2 | Near-infrared nerve-sparing fluorophores | NTRK1, PMP22, GAP43 | KCNH2 195/4885ALDH1A1 813/4885HSD17B10 1810/4885 |
| US-20230148317-A1 | OXAZINE-BASED FLUOROPHORE COMPOUNDS FOR NERVE-SPECIFIC IMAGING | GAP43, NTRK1, CHAT | KCNH2 530/4885ALDH1A1 1300/4885HSD17B10 2874/4885 |
| US-12605468-B2 | Oxazine-based fluorophore compounds for nerve-specific imaging | CHRNB2, CHRNB3, CHRNB4 | KCNH2 204/4885ALDH1A1 1339/4885HSD17B10 2385/4885 |
| US-12011433-B2 | Mofezolac derivatives as multi-functions selective COX-1 inhibitors | PTGS1, HMOX1, HMGB1 | KCNH2 4242/4885ALDH1A1 648/4885HSD17B10 3127/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.